1-12 of 12
Gerald L. DeNardo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2703: Effect of route and dosing regimen on efficacy of SH7139 in mouse Burkitt's lymphoma xenografts

Rodney Balhorn, Gary Mirick, Gerald L. DeNardo, Laurel Beckett, Judy Li, Saphon Hok, Monique Balhorn
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2703.
https://doi.org/10.1158/1538-7445.AM2014-2703
Published: 01 October 2014
View article titled, Abstract 2703: Effect of route and dosing regimen on efficacy of SH7139 in mouse Burkitt's lymphoma xenografts
Journal Articles

Abstract 5460: Intracellular uptake and metabolism of SH7139: Is it a targeted prodrug for B-cell lymphomas

Monique C. Balhorn, Gary Mirick, Dong Cheng, Zhengping Ma, Edmond Y. Lau, Saphon Hok, Gerald L. DeNardo, Rod Balhorn
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5460.
https://doi.org/10.1158/1538-7445.AM2014-5460
Published: 01 October 2014
View article titled, Abstract 5460: Intracellular uptake and metabolism of SH7139: Is it a targeted prodrug for B-cell lymphomas
Journal Articles

Development of synthetic high affinity ligands that bind to a structural epitope on the tumor cell receptor HLA-DR10

Rod Balhorn, Julie Perkins, Patricia A. Burke, Felice C. Lightstone, Monique Cosman, Ceslovas Venclovas, Michele Corzett, Sally J. Denardo, Terry A. Lehner, Jeff P. Gregg, Huguette Albrecht, Gerald L. Denardo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 902–903.
Published: 01 May 2005
View article titled, Development of synthetic high affinity ligands that bind to a structural epitope on the tumor cell receptor HLA-DR10
Journal Articles

Development of scFv modular PEGylated pharmaceuticals for pretargeted radiation therapy

Huguette Albrecht, Sally J. Denardo, Cheng-Yi Cheng, Arutselvan Natarajan, Gerald L. Denardo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 285–286.
Published: 01 May 2005
View article titled, Development of scFv modular PEGylated pharmaceuticals for pretargeted radiation therapy
Journal Articles

Cilengitide Targeting of αvβ3 Integrin Receptor Synergizes with Radioimmunotherapy to Increase Efficacy and Apoptosis in Breast Cancer Xenografts

Patricia A. Burke, Sally J. DeNardo, Laird A. Miers, Kathleen R. Lamborn, Siegfried Matzku, Gerald L. DeNardo
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4263–4272.
Published: 01 August 2002
View article titled, Cilengitide Targeting of α<sub>v</sub>β<sub>3</sub> Integrin Receptor Synergizes with Radioimmunotherapy to Increase Efficacy and Apoptosis in Breast Cancer Xenografts
Open the PDF for Cilengitide Targeting of α<sub>v</sub>β<sub>3</sub> Integrin Receptor Synergizes with Radioimmunotherapy to Increase Efficacy and Apoptosis in Breast Cancer Xenografts in another window
Journal Articles

Radioimmunotherapy for Breast Cancer Using Escalating Fractionated Doses of 131I-labeled Chimeric L6 Antibody with Peripheral Blood Progenitor Cell Transfusions

Carol M. Richman, Sally J. DeNardo, Lois F. O'Grady, Gerald L. DeNardo
Journal: Cancer Research
Cancer Res (1995) 55 (23_Supplement): 5916s–5920s.
Published: 01 December 1995
View article titled, Radioimmunotherapy for Breast Cancer Using Escalating Fractionated Doses of <sup>131</sup>I-labeled Chimeric L6 Antibody with Peripheral Blood Progenitor Cell Transfusions
Open the PDF for Radioimmunotherapy for Breast Cancer Using Escalating Fractionated Doses of <sup>131</sup>I-labeled Chimeric L6 Antibody with Peripheral Blood Progenitor Cell Transfusions in another window
Journal Articles

Prognostic Factors for Radioimmunotherapy in Patients with B-Lymphocytic Malignancies

Gerald L. DeNardo, Kathleen R. Lamborn, Sally J. DeNardo, Desirée S. Goldstein, Edward G. Dolber-Smith, Linda A. Kroger, Edward C. Larkin, Sui Shen
Journal: Cancer Research
Cancer Res (1995) 55 (23_Supplement): 5893s–5898s.
Published: 01 December 1995
View article titled, Prognostic Factors for Radioimmunotherapy in Patients with B-Lymphocytic Malignancies
Open the PDF for Prognostic Factors for Radioimmunotherapy in Patients with B-Lymphocytic Malignancies in another window
Journal Articles

Yttrium-90 Chimeric L6 Therapy of Human Breast Cancer in Nude Mice and Apoptosis-related Messenger RNA Expression

Sally J. DeNardo, Paul H. Gumerlock, Michelle D. Winthrop, Philip C. Mack, Sung-Gil Chi, Kathleen R. Lamborn, Sui Shen, Laird A. Miers, Ralph W. deVere White, Gerald L. DeNardo
Journal: Cancer Research
Cancer Res (1995) 55 (23_Supplement): 5837s–5841s.
Published: 01 December 1995
View article titled, Yttrium-90 Chimeric L6 Therapy of Human Breast Cancer in Nude Mice and Apoptosis-related Messenger RNA Expression
Open the PDF for Yttrium-90 Chimeric L6 Therapy of Human Breast Cancer in Nude Mice and Apoptosis-related Messenger RNA Expression in another window
Journal Articles

Effect of the Extent of Chelate Substitution on the Immunoreactivity and Biodistribution of 2IT-BAT-Lym-1 Immunoconjugates

David L. Kukis, Gerald L. DeNardo, Sally J. DeNardo, Gary R. Mirick, Laird A. Miers, Douglas P. Greiner, Claude F. Meares
Journal: Cancer Research
Cancer Res (1995) 55 (4): 878–884.
Published: 01 February 1995
View article titled, Effect of the Extent of Chelate Substitution on the Immunoreactivity and Biodistribution of 2IT-BAT-Lym-1 Immunoconjugates
Open the PDF for Effect of the Extent of Chelate Substitution on the Immunoreactivity and Biodistribution of 2IT-BAT-Lym-1 Immunoconjugates in another window
Journal Articles

Fractionated Radioimmunotherapy of B-Cell Malignancies with 131I-Lym-1

Gerald L. DeNardo, Sally J. DeNardo, Lois F. O'Grady, Norman B. Levy, Gregory P. Adams, Stanley L. Mills
Journal: Cancer Research
Cancer Res (1990) 50 (3_Supplement): 1014s–1016s.
Published: 01 February 1990
View article titled, Fractionated Radioimmunotherapy of B-Cell Malignancies with <sup>131</sup>I-Lym-1
Open the PDF for Fractionated Radioimmunotherapy of B-Cell Malignancies with <sup>131</sup>I-Lym-1 in another window
Journal Articles

Effect of Mass of 111In-Benzyl-EDTA Monoclonal Antibody on Hepatic Uptake and Processing in Mice

Gregory P. Adams, Sally J. DeNardo, Shrikant V. Deshpande, Gerald L. DeNardo, Claude F. Meares, Michael J. McCall, Alan L. Epstein
Journal: Cancer Research
Cancer Res (1989) 49 (7): 1707–1711.
Published: 01 April 1989
View article titled, Effect of Mass of <sup>111</sup>In-Benzyl-EDTA Monoclonal Antibody on Hepatic Uptake and Processing in Mice
Open the PDF for Effect of Mass of <sup>111</sup>In-Benzyl-EDTA Monoclonal Antibody on Hepatic Uptake and Processing in Mice in another window
Journal Articles

Blood Flow in Irradiated Mouse Sarcoma as Determined by the Clearance of Xenon-133

Robert F. Kallman, Gerald L. DeNardo, Mary J. Stasch
Journal: Cancer Research
Cancer Res (1972) 32 (3): 483–490.
Published: 01 March 1972
View article titled, Blood Flow in Irradiated Mouse Sarcoma as Determined by the Clearance of Xenon-133
Open the PDF for Blood Flow in Irradiated Mouse Sarcoma as Determined by the Clearance of Xenon-133 in another window